Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms

BACKGROUND: Despite timely administration of IVIG, some patients with Kawasaki disease (KD) develop rapidly progressive or giant coronary artery aneurysms (CAA). CASE PRESENTATION: We describe our experience using cyclophosphamide (CYC) for the treatment of such cases as well as a review of the lite...

Descripción completa

Detalles Bibliográficos
Autores principales: Halyabar, Olha, Friedman, Kevin G., Sundel, Robert P., Baker, Annette L., Chang, Margaret H., Gould, Patrick W., Newburger, Jane W., Son, Mary Beth F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968156/
https://www.ncbi.nlm.nih.gov/pubmed/33731148
http://dx.doi.org/10.1186/s12969-021-00526-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968156/
https://www.ncbi.nlm.nih.gov/pubmed/33731148
http://dx.doi.org/10.1186/s12969-021-00526-0

Ejemplares similares